AltPep Corporation. is a biomedical company based along Seattle's Lake Union developing groundbreaking disease-modifying treatments and detection tools for amyloid diseases by targeting a novel early molecular trigger: alpha sheet oligomers. Our lead programs focus on Alzheimer’s and Parkinson’s diseases, with other amyloid diseases on the horizon. AltPep’s goal is to change the course of these debilitating diseases that affect over a billion peo...
